JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 1 Relative risk for major adverse cardiovascular events (MACE) up to nine months in randomized trials of the TAXUS paclitaxel-eluting stent; MACE is composite occurrence of cardiovascular death, myocardial infarction, or target vessel revascularization (see text). MR = moderate release; SR = slow release.





Right arrow Return to article

HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK